Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-30.87
Price to sales ratio
0.74

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4633
LGVN
Longeveron Inc. - Class A Common stock
0.62 USD-1.59%-3.13%-24.39%+8.52%19.31 M USD
4634
KALA
KALA BIO, Inc. - Common Stock
0.96 USD-11.93%-36.42%-64.18%-83.45%17.85 M USD
4637
ATOS
Atossa Therapeutics, Inc. - Common Stock
2.24 USD-6.67%-10.04%-10.76%+138.30%19.29 M USD
4638
LPCN
Lipocine Inc. - Common Stock
2.31 USD-1.70%-3.35%+2.21%-20.34%19.04 M USD

Frequently asked questions about Neuphoria Therapeutics Inc. - Common Stock

What is the Neuphoria Therapeutics Inc. - Common Stock stock price today?

The current price of Neuphoria Therapeutics Inc. - Common Stock (NEUP) is 3.51. Over the past 24 hours, the stock has changed by +0.57%. Follow the NEUP chart for real-time price dynamics.

What is the stock ticker of Neuphoria Therapeutics Inc. - Common Stock?

Neuphoria Therapeutics Inc. - Common Stock trades under the ticker NEUP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Neuphoria Therapeutics Inc. - Common Stock stock going up?

NEUP has changed by -2.23% over the last week, -22.86% over the last month, and -54.12% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Neuphoria Therapeutics Inc. - Common Stock have?

As of the latest available data, Neuphoria Therapeutics Inc. - Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Neuphoria Therapeutics Inc. - Common Stock stock?

You can buy Neuphoria Therapeutics Inc. - Common Stock (NEUP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Neuphoria Therapeutics Inc. - Common Stock stock?

Investing in Neuphoria Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NEUP chart and related analysis on metatrader.com as part of your research.